American Century Companies’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding PGNX
BC
BBA
PA
BFA
American Century Companies's PGNX Position: Q2 2016 in Review
American Century Companies sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2016, closing a stake of 172,506 shares — an estimated $752K sold.
American Century Companies first reported a position in PGNX in Q2 2015 and held it in 4 quarters. The position peaked at $752K in Q1 2016. 104 funds tracked by Wall St. Rank hold PGNX as of Q2 2016.
- American Century Companies reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
- American Century Companies sold 172,506 Progenics Pharmaceuticals Inc shares in Q2 2016, an estimated $752K.
- American Century Companies first reported a position in Progenics Pharmaceuticals Inc in Q2 2015 and held it in 4 quarters.
- American Century Companies's Progenics Pharmaceuticals Inc position peaked at $752K in Q1 2016.
- 104 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2016.
Based on American Century Companies's 13F filing for Q2 2016, filed 26 Jul 2016.